Effects of B Cell Depletion by CD19-targeted CAR-T Cells in a Murine Model of Systemic Sclerosis

被引：0
|
作者：
Avouac, Jerome [1 ]
Cauvet, Anne [2 ]
Orvain, Cindy [2 ]
Boulch, Morgane [3 ]
Bousso, Philippe [3 ]
Allanore, Yannick [4 ]
机构：
[1] Univ Paris Cite, Hop Cochin, AP HP, Serv Rhumatol, Paris, France
[2] INSERM, U1016, Paris, France
[3] Inst Pasteur, Paris, France
[4] Univ Paris Cite, Paris, France
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0956
引用
收藏
页码：1882 / 1883
页数：2
相关论文
共 50 条
  • [21] Understanding Outcomes of CD19-Targeted CAR T Cell Immunotherapy
    Turtle, Cameron J.
    BLOOD, 2017, 130
  • [22] CD19-targeted CAR T cells in refractory antisynthetase syndrome
    Mueller, Fabian
    Boeltz, Sebastian
    Knitza, Johannes
    Aigner, Michael
    Voelkl, Simon
    Kharboutli, Soraya
    Reimann, Hannah
    Taubmann, Jule
    Kretschmann, Sascha
    Roesler, Wolf
    Manger, Bernhard
    Wacker, Jochen
    Mougiakakos, Dimitrios
    Jabari, Samir
    Schroeder, Rolf
    Uder, Michael
    Roemer, Frank
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    LANCET, 2023, 401 (10379): : 815 - 818
  • [23] Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
    Maher, John
    CURRENT GENE THERAPY, 2014, 14 (01) : 35 - 43
  • [24] Comment on: Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies
    Ruffer, Nikolas
    Krusche, Martin
    Stenzel, Werner
    Schneider, Udo
    RHEUMATOLOGY, 2023, 63 (11) : e309 - e311
  • [25] In vivo Inhibition of Human CD19-Targeted Effector T Cells by Natural T Regulatory Cells in a Xenotransplant Murine Model of B Cell Malignancy
    Lee, James C.
    Hayman, Erik
    Pegram, Hollie J.
    Santos, Elmer
    Heller, Glenn
    Sadelain, Michel
    Brentjens, Renier
    CANCER RESEARCH, 2011, 71 (08) : 2871 - 2881
  • [26] Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
    Paszkiewicz, Paulina J.
    Fraessle, Simon P.
    Srivastava, Shivani
    Sommermeyer, Daniel
    Hudecek, Michael
    Drexler, Ingo
    Sadelain, Michel
    Liu, Lingfeng
    Jensen, Michael C.
    Riddell, Stanley R.
    Busch, Dirk H.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (11): : 4262 - 4272
  • [27] CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients
    Mueller, Fabian
    Voelkl, Simon
    Mougiakakos, Dimitrios
    Boeltz, Sebastian
    Aigner, Michael
    Gary, Regina
    Kretschmann, Sascha
    Kharboutli, Soraya
    Kleyer, Arnd
    Simon, David
    Roesler, Wolf
    Habenicht, Katharina M.
    Winkler, Thomas H.
    Kroenke, Gerhard
    Schett, Georg
    Mackensen, Andreas
    BLOOD, 2022, 140 : 4562 - 4563
  • [28] Reverse fate mapping of CD19-targeted CAR T cells in patients with large B-cell lymphoma
    Good, Zinaida
    Hamilton, Mark P.
    Spiegel, Jay Y.
    Kurra, Sreevidya
    Desai, Moksha
    Prabhu, Snehit
    Yang, Eric
    Ozawa, Michael G.
    Hanson, Paul J.
    Wu, Fang
    Frank, Matthew J.
    Baird, John H.
    Muffly, Lori
    Claire, Gursharan K.
    Craig, Juliana
    Kong, Katherine A.
    Wagh, Dhananjay
    Coller, John
    Plevritis, Sylvia K.
    Sahaf, Bita
    Miklos, David B.
    Mackall, Crystal L.
    CANCER RESEARCH, 2022, 82 (12)
  • [29] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis
    Avouac, Jerome
    LANCET RHEUMATOLOGY, 2025, 7 (02): : e74 - e75
  • [30] CD19-Targeted CAR T Cell Therapy for Concomitant Diffuse Large B Cell Lymphoma and Myeloma
    D'Ovidio, Tyler J.
    Ciccolini, Kathryn
    Kalac, Matko
    Osman, Keren
    Steinberg, Amir
    BLOOD, 2021, 138
12345